INS and obesity disorder: A central role for adipose ChREBPβ isoform in insulin sensitivity was suggested in different models of obesity and glucose intolerance where expression of ChREBPβ in white adipose tissue strongly correlates with lipogenic activity and systemic insulin sensitivity (5, 7–9).